Dyne Therapeutics, Inc.
DYN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001818794
In the last 90 days, Dyne Therapeutics, Inc. insiders filed 0 open-market purchases and 10 sales; 245 institutions reported holding it in 13F filings for Q2 2026, worth $4.23B in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Dyne Therapeutics, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 205
- +7 vs. Q4 2024
- Shares held
- 122.0M
- +10.6M (+9.6%) vs. Q4 2024
- Total value
- $1.29B
- −$1.34B (−50.9%) vs. Q4 2024
- New holders
- 50
- 81 more added
- Sold out
- 43
- 44 more reduced
2 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DYN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 245 | $4.23B |
| Q1 2026 | 228 | $3.40B |
| Q4 2025 | 233 | $3.48B |
| Q3 2025 | 207 | $1.97B |
| Q2 2025 | 198 | $1.22B |
| Q1 2025 | 205 | $1.29B |
| Q4 2024 | 200 | $2.63B |
| Q3 2024 | 200 | $4.03B |
| Q2 2024 | 193 | $3.92B |
| Q1 2024 | 169 | $2.71B |
| Q4 2023 | 124 | $930.0M |
| Q3 2023 | 114 | $536.6M |
| Q2 2023 | 118 | $665.9M |
| Q1 2023 | 127 | $628.7M |
| Q4 2022 | 113 | $576.2M |
| Q3 2022 | 102 | $565.8M |
| Q2 2022 | 90 | $320.7M |
| Q1 2022 | 94 | $456.6M |
| Q4 2021 | 93 | $568.3M |
| Q3 2021 | 83 | $572.8M |
| Q2 2021 | 76 | $753.4M |
| Q1 2021 | 75 | $533.3M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Dyne Therapeutics, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 7,406,344 | $77.5M | 0.00% | +702,418+10.5% | Added |
| BlackRock, Inc. | 8,046,938 | $84.2M | 0.00% | +97,536+1.2% | Added |
| Atlas Venture Life Science Advisors, LLC | 9,130,465 | $95.5M | 18.30% | +1,111,111+13.9% | Added |
| Ra Capital Management, L.P. | 9,714,392 | $101.6M | 1.70% | +3,333,248+52.2% | Added |
| Janus Henderson Group PLC | 10,353,416 | $118.5M | 0.06% | +2,974,107+40.3% | Added |
| Holocene Advisors, LP | 0 | $0 | 0.00% | −2,348,161−100.0% | Sold out |
| Adage Capital Partners GP, L.L.C. | 0 | $0 | 0.00% | −1,950,000−100.0% | Sold out |
| Jefferies Financial Group Inc. | 0 | $0 | 0.00% | −1,800,000−100.0% | Sold out |
| Jennison Associates LLC | 0 | $0 | 0.00% | −1,211,915−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −1,056,241−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −746,463−100.0% | Sold out |
| Octagon Capital Advisors LP | 0 | $0 | 0.00% | −668,000−100.0% | Sold out |
| EcoR1 Capital, LLC | 0 | $0 | 0.00% | −555,644−100.0% | Sold out |
| First Light Asset Management, LLC | 0 | $0 | 0.00% | −420,431−100.0% | Sold out |
| Vida Ventures Advisors, LLC | 0 | $0 | 0.00% | −407,499−100.0% | Sold out |
| Eventide Asset Management, LLC | 0 | $0 | 0.00% | −332,277−100.0% | Sold out |
| Pictet Asset Management Holding SA | 0 | $0 | 0.00% | −323,552−100.0% | Sold out |
| Crestline Management, LP | 0 | $0 | 0.00% | −184,818−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −169,306−100.0% | Sold out |
| Neuberger Berman Group LLC | 0 | $0 | 0.00% | −152,306−100.0% | Sold out |
| Prudential Financial Inc | 0 | $0 | 0.00% | −145,510−100.0% | Sold out |
| Springhill Fund Asset Management (HK) Co Ltd | 0 | $0 | 0.00% | −131,200−100.0% | Sold out |
| Avidity Partners Management LP | 0 | $0 | 0.00% | −96,000−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −76,100−100.0% | Sold out |
| Superstring Capital Management LP | 0 | $0 | 0.00% | −73,150−100.0% | Sold out |
| Lisanti Capital Growth, LLC | 0 | $0 | 0.00% | −57,755−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −50,911−100.0% | Sold out |
| Hudson Bay Capital Management LP | 0 | $0 | 0.00% | −35,000−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −28,781−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −24,501−100.0% | Sold out |
| Syon Capital LLC | 0 | $0 | 0.00% | −16,930−100.0% | Sold out |
| Allianz Asset Management GmbH | 0 | $0 | 0.00% | −15,800−100.0% | Sold out |
| Legato Capital Management LLC | 0 | $0 | 0.00% | −12,960−100.0% | Sold out |
| Magnetar Financial LLC | 0 | $0 | 0.00% | −11,181−100.0% | Sold out |
| FORA Capital, LLC | 0 | $0 | 0.00% | −9,235−100.0% | Sold out |
| Neo Ivy Capital Management | 0 | $0 | 0.00% | −8,715−100.0% | Sold out |
| Virtus ETF Advisers LLC | 0 | $0 | 0.00% | −2,776−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −1,100−100.0% | Sold out |
| Steward Partners Investment Advisory, LLC | 0 | $0 | 0.00% | −610−100.0% | Sold out |
| R Squared Ltd | 0 | $0 | 0.00% | −440−100.0% | Sold out |
| Spire Wealth Management | 0 | $0 | 0.00% | −300−100.0% | Sold out |
| Venturi Wealth Management, LLC | 0 | $0 | 0.00% | −270−100.0% | Sold out |
| Asset Dedication, LLC | 0 | $0 | 0.00% | −103−100.0% | Sold out |
| Bellevue Asset Management, LLC | 0 | $0 | 0.00% | −47−100.0% | Sold out |
| Smartleaf Asset Management LLC | 0 | $0 | 0.00% | −31−100.0% | Sold out |
| J.Safra Asset Management Corp | 0 | $0 | 0.00% | −11−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| Farther Finance Advisors, LLC | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| Nuveen Asset Management, LLC | – | – | – | – | Not filed |
| Global Retirement Partners, LLC | – | – | – | – | Not filed |